Literature DB >> 10966989

Antibodies to phosphatidylethanolamine and phosphatidylserine are associated with increased natural killer cell activity in non-male factor infertility patients.

G Sher1, J D Fisch, G Maassarani, W Matzner, W Ching, P Chong.   

Abstract

Antiphospholipid antibodies (APA) have been identified in patients with recurrent pregnancy loss and IVF failure. Of these, antiphosphatidylethanolamine (aPE) and antiphosphatidylserine (aPS) may have special significance. A link between increased natural killer cell activity (NKa+) and trophoblast cell apoptosis has also been reported. This study was undertaken to determine how the APA profile was associated with peripheral NK cell activity. We evaluated 197 female IVF candidates for APA and NKa. Eighty-nine patients (45%) were APA+ and of these, 51 (57%) were aPE/aPS+. Fifty-four patients (27%) had increased NK cell activity. Some 51% of APA+ and 78% of aPE/aPS+ patients had increased NK cell activity compared with 8% and 13% when APA and aPE/aPS tested negative respectively (P: < 0.0001). Non-male factor infertility patients were APA+ and NKa+ in 57% and 34% of cases respectively, compared with 19% and 13% if a pure male factor was present. Some 88% of aPE/aPS+, non-male factor patients had increased NK cell activity, compared with 12% who tested aPE/aPS negative (P: < 0.0001) and 25% of aPE/aPS+, isolated male factor patients (P: < 0.0001). These findings establish a direct relationship between APA (specifically aPE/aPS) and increased peripheral NK cell activity among non-male factor infertility patients. It is possible that APA do not directly cause reproductive failure but rather function as markers or intermediaries for an underlying, abnormal activation of cellular immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966989     DOI: 10.1093/humrep/15.9.1932

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

Review 1.  Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 2.  Management of obstetric antiphospholipid syndrome.

Authors:  Guilherme Ribeiro Ramires de Jesus; Flavia Cunha dos Santos; Camila Souto Oliveira; Wallace Mendes-Silva; Nilson Ramires de Jesus; Roger Abramino Levy
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

3.  The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.

Authors:  Songwang Hou; Paul E Harper; Nathalie Bardin; Ming Zhao
Journal:  J Immunol Methods       Date:  2016-10-23       Impact factor: 2.303

Review 4.  NK cells, autoantibodies, and immunologic infertility: a complex interplay.

Authors:  Caterina De Carolis; Carlo Perricone; Roberto Perricone
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

Review 5.  Anti-phospholipid antibodies and infertility.

Authors:  H J A Carp; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

6.  The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles.

Authors:  Roberto Matorras; Ibon Martinez-Arranz; Enara Arretxe; Marta Iruarrizaga-Lejarreta; Blanca Corral; Jone Ibañez-Perez; Antonia Exposito; Begoña Prieto; Felix Elortza; Cristina Alonso
Journal:  J Assist Reprod Genet       Date:  2019-12-21       Impact factor: 3.412

7.  Association of the leukemia inhibitory factor gene mutation and the antiphospholipid antibodies in the peripheral blood of infertile women.

Authors:  M Králícková; Z Ulcová-Gallová; R Síma; T Vanecek; P Síma; J Krizan; R Suchá; P Uher; O Hes; Z Novotný; Z Rokyta; V Vetvicka
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.